Coris Bioconcept develops and manufactures rapid diagnostic tests

Innovative solutions
    for more effective diagnostics

Presentation

Products

Pathogens

Client Care

Science

IFU

Contact

Blog

NEWS

AACC 2018 - Meet us in Chicago

July 31 to August 2, 2018

 

Products Range

NEW-Resist Range

NEW OXA-23

NEW RESIST-4 O.K.N.V.

Oxa-48

KPC

RESIST-3 O.O.K.

RESIST-3 O.K.N.

Immunochromatographic Range

Pathogens detection

40/41 Adenovirus

Adenovirus

Clostridium difficile

Cryptosporidium & Giardia

Cryptosporidium

Escherichia coli O157

Rotavirus & 40/41 Adenovirus

Giardia

Helicobacter pylori

Influenza A & B viruses

Legionella

Respiratory Adenovirus

Rotavirus & Adenovirus

Rotavirus

Respiratory Syncytial Virus (RSV)

Streptococcus (group A)

Trypanosoma brucei gambiense (HAT)

Quatro-VeT (Veterinary)

Molecular Range

Leishmania

Pseudomonas aeruginosa

Scientific partners

INNPAPER

PARADIS (Biowin)

AquaVir (FP7)

Nareb (FP7)

Euroleish (H2020-MSCA-ITN)

ebolaMoDRAD (IMI-2)

 

Presentation  >  Company Profile

Coris BioConcept Building

Company Profile

Based in Belgium and established in 1996, Coris BioConcept is a middle-sized company (SME) specialized in developing, manufacturing and marketing rapid diagnostic kits for the detection of human respiratory and gastro-enteric infectious pathogens (bacteria, viruses and parasites) and for the detection of antibiotic resistance markers (RESIST range). These tests are based on the lateral flow immunochromatography technology with colloidal gold particles or latex microspheres. These rapid tests are extensively used in microbiology  laboratories worldwide.

To complement this extensive range of fast and accurate lateral flow tests, the company has developed an innovative automated platform that performs multiplex PCR amplification and detection on a microfluidic cartridge (TRAPIST® system). This molecular multiplex platform allows syndromic diagnostic approaches for the clinical management of main human infections and resistance to antibiotics.

Coris BioConcept provides services for custom tests development and contract manufacturing. The company is present in more than 60 countries in Europe, Asia, South America, Africa and Oceania.

Coris BioConcept is continually involved in collaborative projects with Belgian and European Research Institutes, laboratories and companies for the development of breaking new solutions.

All Coris BioConcept’s products fulfil the CE marking requirements and the company is also  ISO 13485 certified.

Our Quality Management System is covering “Design, development, manufacture and distribution of in vitro diagnostic devices for the detection of pathogens in the diagnosis of respiratory, gastric, enteric and parasitic diseases, the detection of resistance to antibiotics and the detection in urine of therapeutics, used for the treatment of these infectious diseases”.

 

Home   -   Site Map   -   Privacy Policy   -   Contact   -   FAQ                   All rights reserved CorisBioconcept SPRL 1996-2012©                           www.corisbio.com

Web traffic Optimisation
Universem

Design, Programming & hosting
Impact communication